BUZZ-U.S. STOCKS ON THE MOVE-Juno Therapeutics, Finish Line, NQ Mobile, ImmunoGen
(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for the Day Ahead newsletter, link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s) U.S. stocks were little changed on Friday, after the Federal Reserve's most recent policy statement sparked the best two-day run for the benchmark S&P 500 in three years.
The Dow Jones industrial average was up 0.09 percent at 17,794.07, the S&P 500 was up 0.25 percent at 2,066.42 and the Nasdaq Composite was up 0.23 percent at 4,759.186.
** JUNO THERAPEUTICS INC, $37.52, +56.33 pct
Shares of the biopharmaceutical company working on cancer treatments, rose as much as 64.5 percent in their market debut, valuing the company at about $3 billion.
** IMMUNOGEN INC, $6.02, -44.52 pct
Roche said its new cancer drug, Kadcyla, failed to demonstrate an added benefit in breast cancer. Immunogen contributes technology to Kadcyla. ImmunoGen said it expects no impact on its 2015 forecast from the results.